Ubrogepant

Ubrogepant, a novel medication for migraine treatment, has garnered significant attention since its approval. As an oral CGRP receptor antagonist, ubrogepant offers a new approach to acute migraine management. This article explores the real-world efficacy, tolerability, and safety of ubrogepant, shedding light on its potential as a game-changer for migraine sufferers. Introduction to Ubrogepant Ubrogepant … Read more